230 related articles for article (PubMed ID: 20875651)
1. Citicoline, use in cognitive decline: vascular and degenerative.
García-Cobos R; Frank-García A; Gutiérrez-Fernández M; Díez-Tejedor E
J Neurol Sci; 2010 Dec; 299(1-2):188-92. PubMed ID: 20875651
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.
Conant R; Schauss AG
Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642
[TBL] [Abstract][Full Text] [Related]
3. CDP-choline: pharmacological and clinical review.
Secades JJ; Frontera G
Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
[TBL] [Abstract][Full Text] [Related]
4. Citicoline: pharmacological and clinical review, 2006 update.
Secades JJ; Lorenzo JL
Methods Find Exp Clin Pharmacol; 2006 Sep; 28 Suppl B():1-56. PubMed ID: 17171187
[TBL] [Abstract][Full Text] [Related]
5. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
Fioravanti M; Yanagi M
Cochrane Database Syst Rev; 2005 Apr; (2):CD000269. PubMed ID: 15846601
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of mild cognitive impairment: value of citicoline].
Abad-Santos F; Novalbos-Reina J; Gallego-Sandín S; García AG
Rev Neurol; 2002 Oct 1-15; 35(7):675-82. PubMed ID: 12389156
[TBL] [Abstract][Full Text] [Related]
7. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
[TBL] [Abstract][Full Text] [Related]
8. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
Fioravanti M; Yanagi M
Cochrane Database Syst Rev; 2000; (2):CD000269. PubMed ID: 10796523
[TBL] [Abstract][Full Text] [Related]
9. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
Fioravanti M; Yanagi M
Cochrane Database Syst Rev; 2000; (4):CD000269. PubMed ID: 11034681
[TBL] [Abstract][Full Text] [Related]
10. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
Fioravanti M; Yanagi M
Cochrane Database Syst Rev; 2004; (2):CD000269. PubMed ID: 15106147
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC
Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981
[TBL] [Abstract][Full Text] [Related]
12. The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives.
Gareri P; Castagna A; Cotroneo AM; Putignano S; De Sarro G; Bruni AC
Clin Interv Aging; 2015; 10():1421-9. PubMed ID: 26366063
[TBL] [Abstract][Full Text] [Related]
13. [The current state of citicholine in cerebral ischemia].
Abad-Santos F; Gallego-Sandín S; Novalbos J; Gálvez-Múgica MA
Rev Neurol; 2000 Apr 1-15; 30(7):663-70. PubMed ID: 10859748
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
Parnetti L; Mignini F; Tomassoni D; Traini E; Amenta F
J Neurol Sci; 2007 Jun; 257(1-2):264-9. PubMed ID: 17331541
[TBL] [Abstract][Full Text] [Related]
15. CDP-choline as a biological supplement during neurorecovery: a focused review.
Arenth PM; Russell KC; Ricker JH; Zafonte RD
PM R; 2011 Jun; 3(6 Suppl 1):S123-31. PubMed ID: 21703569
[TBL] [Abstract][Full Text] [Related]
16. Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes.
Cohen RA; Browndyke JN; Moser DJ; Paul RH; Gordon N; Sweet L
Cerebrovasc Dis; 2003; 16(3):199-204. PubMed ID: 12865605
[TBL] [Abstract][Full Text] [Related]
17. Citicoline in vascular cognitive impairment and vascular dementia after stroke.
Alvarez-Sabín J; Román GC
Stroke; 2011 Jan; 42(1 Suppl):S40-3. PubMed ID: 21164117
[TBL] [Abstract][Full Text] [Related]
18. [Citicoline in the treatment of cognitive and behavioral disorders in pathologic senile decline].
Di Trapani G; Fioravanti M
Clin Ter; 1991 Jun; 137(6):403-13. PubMed ID: 1832612
[TBL] [Abstract][Full Text] [Related]
19. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
Tariska P; Paksy A
Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
[TBL] [Abstract][Full Text] [Related]
20. Citicoline. Ferrer Internacional.
Alexandrov AV
Curr Opin Investig Drugs; 2001 Dec; 2(12):1757-62. PubMed ID: 11892942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
